Nitric oxide and prostaglandins in the clenbuterol-induced ACTH and corticosterone secretion

Journal of Physiology and Pharmacology

Volumn 59, Issue 1, 2008, Pages 163-175

  Gadek Michalska A ^a   Bugajski, A J ^b   Bugajski, J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

2 adrenergic receptors; Clenbuterol; NO; PG; Social stress; Stimulation of HPA axis

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; CLENBUTEROL; CORTICOSTERONE; CORTICOTROPIN; ISOPRENALINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PIROXICAM; PROPRANOLOL; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; CORTICOTROPIN RELEASE; CROWDING; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG SELECTIVITY; HORMONAL REGULATION; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SOCIAL STRESS;

ADRENERGIC BETA-AGONISTS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CLENBUTEROL; CORTICOSTERONE; CROWDING; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; NITRIC OXIDE; PITUITARY-ADRENAL SYSTEM; PROSTAGLANDINS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-2; STRESS, PSYCHOLOGICAL;

EID: 42049098400     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Illera JC, Silvan G, Blass A, Martinez MM, Illera M. The effects of clenbuterol on adrenal function in rats. Analyst 1998; 123: 2521-2524.
2. Silvan G, Martinez-Mateos MM, Blass A, Camacho L, Gonzalez-Gil A, Garcia-Partida P, Illera JC. The effect of long term exposure to combinations of growth promoters in Long Evans rats. Part 1: Endocrine adrenal function. Analytica Chimica Acta 2007; 586: 246-51.
3. Cardoso LA, Stock MJ. Effect of clenbuterol on endocrine status and nitrogen and energy balance in food-restricted rats. J Anim Sci 1998; 76: 1012-1018.
4. Illera JC, Pena L, Martinez-Mateos MM, Camacho L, Blass A, Garcia-Partida P, Illera MJ, Silvan G. The effect of long-term exposure to combinations of growth promotes in Long Evans rats. Part 2. Adrenal morphology (histopathology and immunochemical studies). Analytica Chimica Acta 2007; 586: 252-258.
5. Bugajski J, Głód R, Ga̧dek-Michalska A, Bugajski AJ. Involvement of constitutive (COX-1) and inducible cyclooxygenase (COX-2) in the adrenergic-induced ACTH and corticosterone secretion. J Physiol Pharmacol 2001; 52: 795-809.
6. Garthwaite J. The physiological roles of nitric oxide in the central nervous system. In Nitric Oxide ed. Mayer B, Handbook of Experimental Pharmacology 2000; 143: 259-275.
7. Kiss JP. Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Res Bull 2000; 52: 459-466.
8. Lafuente A, Gonzalez-Carracedo A, Romero A, Cano P, Esquifino AI. Effect of nitric oxide on prolactin secretion and hypothalamic biogenic amine contents. Life Sci 2004; 74: 1681-1690.
9. Stern JE. Nitric oxide and homeostatic control: an intracellular signaling molecule contributing to autonomic and neuroendocrine integration? Prog Biophys Mol Biol 2004; 84: 197-215.
10. Prevot V, Bouret S, Stefano GB, Beauvillain J. Median eminence nitric oxide signaling. Brain Res Brain Res Rev 2000; 34: 27-41.
11. Givalois L, Li S, Pelletier G. Central nitric oxide regulation of the hypothalamic-pituitary-adrenocortical axis in adult male rats. Mol Brain Res 2002; 102: 1-8.
12. Okada S, Murakami, Yokotani K. Centrally applied nitric oxide donor elevates plasma corticosterone by activation of the hypothalamic noradrenergic neurons in rats. Brain Res 2002; 939: 26-33.
13. Seo DO, Lee S, Rivier C. Role of specific adrenergic receptors in mediating the adrenocorticotropic hormone response to increased nitric oxide levels. J Neuroendocrinol 2003; 15: 530-537.
14. Bugajski AJ, Ga̧dek-Michalska A, Bugajski J. The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamic-pituitary-adrenal response during crowding stress. J Physiol Pharmacol 2006; 57: 463-477.
15. Bugajski J, Ga̧dek-Michalska A, Głód R, Borycz J, Bugajski AJ. Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion. J Physiol Pharmacol 1999; 59: 327-334.
16. Kim CK, Rivier CL. Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. Endocrinology 2000; 141: 2244-2253.
17. De Oliveira RMW, Del Bel EA, Mamede-Rosa ML, Padovan CM, Deakin JFW, Guimaraes FS. Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restrain in rats. Neurosci Lett 2000; 289: 123-126.
18. Ericsson A, Arias C, Sawchenko PE. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuity by intravenous interleukin-1. J Neurosci 1997; 17: 7166-7179.
19. Głód R, Ga̧dek-Michalska A, Bugajski J. The influence of indomethacin on the ACTH secretion induced by central stimulation of adrenergic receptors. J Physiol Pharmacol 2000; 51: 347-357.
20. Wang H, Walker SW, Mason JI, Morley SD, Williams BC. Role of arachidonic acid and metabolism in ACTH-stimulated cortisol secretion by bovine adrenocortical cells. Endocr Res 2000; 26: 705-709.
21. Bugajski J, Ga̧dek-Michalska A, Bugajski AJ. Nitric oxide and prostaglandins systems in the stimulation of hypothalamic-pituitary-adrenal axis by neurotransmitters and neurohormones. J Physiol Pharmacol 2004; 55: 679-703.
22. Charmandari E, Tsigos C, Chrousos G. Endocrinology of stress response. Annu Rev Physiol 2005; 67: 259-284.
23. Tamashiro KL, Nguyen MM, Sakai RR. Social stress: from rodents to primates. Front Neuroendocrinol 2005; 26: 27-40.
24. Carrasca GA, Van de Kar LD. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003; 463: 235-272.
25. Flugge G, Van Kampen M, Mijnster MJ. Perturbations in brain monoamine systems during stress. Cell Tissue Res 2004; 315: 1-14.
26. 2- adrenoceptors reduce isoprenaline-induced cardiac fibrisis. Eur J Pharmacol 2004; 485: 227-234.
27. Gambarana C, Ordway GA, Hauptmann M, Tejani-Butt S, Frazer A. Central administration of 1-isoproterenol in vivo induces a preferential regulation of beta 2-adrenoceptors in the central nervous system of the rat. Brain Res 1991; 551: 141-148.
28. Bugajski J, Ga̧dek-Michalska A, Głód R., Bugajski AJ. Effect of social stress on COX-1 and COX-2-induced alterations in the adrenergic agonists-evoked hypothalamic-pituitary-adrenal responses. J Physiol Pharmacol 2001; 52: 811-822.
29. Claing A, Laporte SA, Caron MG, Lefkowitz RJ. Endocytosis of G-protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol 2002; 66: 61-79.
30. von Zastrow M, Kobilka BK. Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. J Biol Chem 1994; 269: 18448-18452.
31. Bornstein SR, Chrousos GP. Adrenocorticotropin (ACTH)- nad non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metabol 1999; 84: 1729-1736. 30.
32. Delarue C, Contesse V, Lenget S, Perraudin V, Lefebvre H, Kodjo M et al. Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex. Rev Endocr Metabol Dis 2001; 2: 253-267. 31.
33. Seo DO, Rivier C. Microinfusion of a nitric oxide donor in discrete brain regions activates the hypothalamus-pituitary-adrenal axis. J Neuroendocrinol 2001; 13: 925-933.
34. Nelson RJ, Trainor BC, Chiavegatto S, Demas GE. Pleiotropic contribution of nitric oxide to aggressive behavior. Neurosci Biobehav Rev 2006: 30: 346-355.
35. Soszyński D, Chelminiak M. Intracerebroventricular injection of neuronal and inducible nitric oxide synthase inhibitors does not influence febrile response in rats during turpentine abscess. J Physiol Pharmacol 2007; 58: 657-667.
36. Ruan Y, Kan H, Malik KU. Beta adrenergic receptor stimulated prostacyclin synthesis in rabbit coronary endothelial cells is mediated by selective activation of phospholipase D inhibitor by adenosine 3′5′-cyclic monophosphate. J Pharmacol Exp Ther 1997; 281: 1038-1046.
37. Krane A, Mac Dermot J, Keen M. Desensitization of adenylate cyclase responses following exposure to IP prostanoid receptor agonists. Homologous and heterologous desensitization exhibit the same time course. Biochem Pharmacol 1994; 15: 953-959.